With the approval of the CE mark, GreenBone officially enters the market with a completely innovative product, which provides orthopedic surgeons and traumatologists with an alternative that can overcome the limits imposed by old generation bone substitutes.
Derived from the biomorphic transformation of rattan wood, GreenBone Bone Substitute™ limits the surgical and postoperative complications related to bone defects created surgically or resulting from traumatic injuries to bones, extremities and pelvis.
Lorenzo Pradella, CEO of GreenBone, says that “the CE mark is a milestone for GreenBone” as it certifies that GreenBone has successfully completed the development of the product and its quality system, ensuring that all the design and production processes of the product comply with ISO13485: 2016 and MDD 93/42 requirements.
Its spread will allow patients a faster return to normal life with their bone completely regenerated, significantly affecting the reduction of health and social costs.
More info press releasse, mark CE 2020
You are entering an area containing information intended for healthcare professionals. If you are a healthcare professional, click here to continue.